Loading
Latest filing published 14 Sept 2021 for 派林生物, €9,729.
Based on 2 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
王志波, listed as chief executive, appears in our data through filings on 派林生物 shares, published by SSE / SZSE (CSRC). We count 2 filings; the first trade dates from 10 September 2021 and the latest from 14 September 2021.
On the market, this insider has only ever bought: 2 purchases, €20k in total. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay.
The record was last updated on 14 September 2021 with an open-market purchase (€9,729) in 派林生物. Source: insider filings from SSE / SZSE (CSRC). Past trades are no guide to future returns.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.